Filter Results:
(324)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
- 25 Jun 2020
- News
Covering All Corners
is coordinating with Gilead Sciences, maker of Remdesivir, to distribute and manufacture the antiviral drug treatment for use in 127 countries, including Egypt. It was recently approved for emergency use by... View Details
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
potential for multiple breakthroughs related to the specific tumor segmentation task of radiation oncologists while also addressing technological issues (e.g., reframing and conducting sequential competition phases). Lagace: What made this problem in cancer View Details
- 08 Jun 2010
- First Look
First Look: June 8
had to be updated to enable collaboration. The current dilemma facing the CEO and COO of the foundation relates to setting strategic priorities for research so that a treatment for MS can be ready in the next ten years. The strategic... View Details
Keywords: Martha Lagace
- 01 Mar 2013
- News
Opening the Door
neighborhood-based health plan for the city of Charlestown, and I became involved in building a system of benchmarks for the various services that were being offered—everything from dental care to drug and alcohol abuse counseling. I... View Details
- 27 Sep 2011
- First Look
First Look: September 27
(forthcoming) An abstract is unavailable at this time. The Variance of Non-Parametric Treatment Effect Estimators in the Presence of Clustering Authors:Samuel G. Hanson and Adi Sunderam Publication:The Review of Economics and Statistics... View Details
Keywords: Sean Silverthorne
- 01 Mar 2006
- News
One-on-One with Dr. Margaret Chan
treatments of the antiviral drug Tamiflu we have ready to dispatch on an emergency basis to contain a pandemic may not be deployed in time. In the case of H5N1, is enough being done to destroy infected... View Details
- 01 Dec 2013
- News
Curing Health Care
Massachusetts Governor Deval Patrick joked in his speech.) Related Links A Blueprint for Patient-Driven Drug Development Gene Williams (MBA 1987) Blavatnik Gift Accelerates Biomedical Advances Oscar Winners Even worse is what... View Details
- 01 Jun 2007
- News
Mission Possible
really works.” Henry McCance (MBA ’66) Cure Alzheimer’s Fund www.curealzfund.org When his wife was diagnosed seven years ago with the early stages of Alzheimer’s disease, Henry McCance found himself searching for the best treatments in... View Details
- 07 Aug 2007
- First Look
First Look: August 7, 2007
their dividend policy to serve their institutional shareholders. Download the paper: http://papers.nber.org/papers/W13283 Taxes and Portfolio Choice: Evidence from JGTRRA's Treatment of International Dividends Authors:Mihir A. Desai and... View Details
Keywords: Martha Lagace
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
in 2001 with Alec Machiels (MBA '01) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug research. "A number of the scientists decided that being part of a... View Details
- 26 Sep 2006
- First Look
First Look: September 26, 2006
the pandemic. Most have not been very successful. An examination of three strategies for distributing antiretroviral drugs (ARVs) to patients in three countries on three continents, Africa, Asia, and South America, suggests a customer... View Details
Keywords: Sean Silverthorne
- 24 Sep 2020
- News
The Race for a Vaccine
a computer model of a potential mRNA-based vaccine. Twenty-five days after that, it produced the first dose of a treatment it hoped would protect against a disease that did not yet have a name. On February 24, after 17 days of analysis... View Details
- 01 Jun 2020
- News
Prognosis
fact that we knew the genetic sequence of it within a few weeks, the fact that there are vaccine candidates being tried in humans, that perhaps we’ll see a drug that is effective against it—the power of biomedical research in the year... View Details
- 01 Jun 2009
- News
Cynthia Carroll
in enterprise development through our incubator units in South Africa and Chile, which support over 220 freestanding businesses providing jobs to some 13,500 people. In South Africa, I’m also very proud that we have the largest workplace HIV testing and View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
and perhaps even refine them more. There's a growing movement and establishment of nonprofit foundations that are participating in drug discovery efforts. These foundations aren't as concerned about intellectual property as they are about... View Details
Keywords: by Martha Lagace
- 27 Mar 2012
- First Look
First Look: March 27
of rapid technological change. Free to Punish? The American Dream and the Harsh Treatment of Criminals Authors:Rafael Di Tella Publication:CATO Papers on Public Policy 1 (2011) Abstract We describe the evolution of selective aspects of... View Details
Keywords: Carmen Nobel
- 04 Aug 2009
- First Look
First Look: August 4
709-474 In 2005, Partners in Health (PIH) was invited by the Rwandan Ministry of Health to assume responsibility for the management of public health care in two rural districts in Eastern Rwanda and create an HIV treatment program at... View Details
Keywords: Martha Lagace
- 01 Dec 2001
- News
Reaching Out
Ph.D. in pathology and molecular biology at Boston University's School of Medicine. Intrigued by his experience with pharmaceutical companies and the role of business in drug delivery, he enrolled at HBS one month after finishing his... View Details
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts... View Details
Keywords: Sean Silverthorne
- 24 May 2011
- First Look
First Look: May 24
decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on... View Details
Keywords: Sean Silverthorne